[Prevention of neonatal infection with Streptococcus Group B. Expert correspondence no. 19 of 29th December 2006].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001431:Bacteriological Techniques; D003428:Cross Infection / Q000401:mortality / Q000517:prevention & control* / Q000635:transmission; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000401:mortality / Q000517:prevention & control*; D018445:Infectious Disease Transmission, Vertical; D015997:Neonatal Screening; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control*; D012307:Risk Factors; D013290:Streptococcal Infections / Q000401:mortality / Q000517:prevention & control* / Q000635:transmission; D013292:Streptococcus agalactiae; D013557:Switzerland; D014626:Vaginal Smears
D000900:Anti-Bacterial Agents